Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 6Phase 1/2 2Phase 1 2Phase 2/3 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Leukemia, Myeloid, Acute 81Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Myelodysplastic Syndromes 22Recurrence 13Congenital Abnormalities 12Lymphoma, Non-Hodgkin 9Leukemia, Biphenotypic, Acute 9Burkitt Lymphoma 9Lymphoma, Mantle-Cell 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Monocytic, Acute 7Hodgkin Disease 7Lymphoma 6Leukemia, Myelomonocytic, Acute 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Myeloproliferative Disorders 4Lymphoma, Follicular 4Lymphoma, B-Cell 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Leukemia, Prolymphocytic 3Leukemia, Myeloid 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Blast Crisis 3

Interventions

Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 8Cyclosporine 8fludarabine phosphate 7Imatinib Mesylate 6Busulfan 5Tacrolimus 4Radiotherapy 4Methotrexate 4Cyclophosphamide 4nilotinib 3bosutinib 3Whole-Body Irradiation 3Cord Blood Stem Cell Transplantation 3Antilymphocyte Serum 3Melphalan 2Filgrastim 2Dasatinib 2Cytarabine 2Alemtuzumab 2sargramostim 1ruxolitinib 1ponatinib 1montanide ISA 51 1liposomal doxorubicin 1ethanolamine oleate 1avelumab 1atezolizumab 1aldesleukin 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Myeloid, Chronic-Phase × Cytarabine × Clear all
NCT00028847 2013-09-17

Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1/2 Unknown
60 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00002761 2012-11-19

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Columbia University

Phase 1/2 Withdrawn
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡